Had1 Is Required for Cell Wall Integrity and Fungal Virulence in Cryptococcus Neoformans

Total Page:16

File Type:pdf, Size:1020Kb

Had1 Is Required for Cell Wall Integrity and Fungal Virulence in Cryptococcus Neoformans G3: Genes|Genomes|Genetics Early Online, published on December 12, 2017 as doi:10.1534/g3.117.300444 1 Had1 is Required for Cell Wall Integrity and Fungal Virulence in 2 Cryptococcus neoformans 3 4 Won-Hee Jung1, Ye-Eun Son1, Sang-Hun Oh2, Ci Fu3, Hye Shin Kim2, Jin-Hwan Kwak2, 5 Maria E. Cardenas3, Joseph Heitman3, and Hee-Soo Park1* 6 7 8 1 School of Food Science and Biotechnology, Institute of Agricultural Science and 9 Technology, Kyungpook National University, Daegu, Republic of Korea; 2 School of Life 10 Science, Handong Global University, Pohang, Republic of Korea; 3 Department of 11 Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North 12 Carolina, USA 13 14 15 16 * Corresponding Author: 17 Hee-Soo Park 18 School of Food Science and Biotechnology 19 80 Daehak-ro, Buk-gu, Daegu, 41566, South Korea 20 Tel: +82-53-950-5751 21 Fax: +82-53-950-6750 22 Email: [email protected] 23 24 Running title: The role of Had1 in C. neoformans. 1 © The Author(s) 2013. Published by the Genetics Society of America. 25 ABSTRACT 26 Calcineurin modulates environmental stress survival and virulence of the human fungal 27 pathogen Cryptococcus neoformans. Previously, we identified 44 putative calcineurin 28 substrates and proposed that the calcineurin pathway is branched to regulate targets 29 including Crz1, Pbp1, and Puf4 in C. neoformans. In this study we characterized Had1, 30 which is one of the putative calcineurin substrates and belongs to a ubiquitously 31 conserved haloacid dehalogenase β-phosphoglucomutase protein super-family. Growth 32 of the had1∆ mutant was found to be compromised at 38C or higher. In addition, the 33 had1∆ mutant exhibited increased sensitivity to cell wall perturbing agents including 34 Congo Red, and Calcofluor White, and to an ER stress inducer DTT. Virulence studies 35 revealed that the had1 mutation results in attenuated virulence compared to the wild 36 type strain in a murine inhalation infection model. Genetic epistasis analysis revealed 37 that Had1 and the zinc finger transcription factor Crz1 play roles in parallel pathways 38 that orchestrate stress survival and fungal virulence. Overall, our results demonstrate 39 that Had1 is a key regulator of thermotolerance, cell wall integrity, and virulence of C. 40 neoformans. 41 42 43 44 45 46 47 48 2 49 INTRODUCTION 50 Calcineurin is a highly conserved serine/threonine protein phosphatase, which is 51 activated by Ca2+/calmodulin in eukaryotic organisms, and plays diverse roles in 52 controlling gene expression and cellular processes (STEWART et al. 1982; RUSNAK AND 2+ 53 MERTZ 2000; ARAMBURU et al. 2004). Increased intracellular Ca levels in response to 54 internal or external cues bind to calmodulin, and in turn, the Ca2+-calmodulin complex 55 interacts with the calcineurin catalytic subunit and activates the phosphatase (CRABTREE 56 2001). Activated calcineurin dephosphorylates target proteins that then orchestrate the 57 response and adaptation to stress (KISSINGER et al. 1995; ARAMBURU et al. 2000). A key 58 substrate of calcineurin is NFAT (nuclear factor of activated T cell), a transcription factor 59 that regulates the expression of genes which are associated with T cell activation, and 60 the development of the nervous and cardiac systems (NORTHROP et al. 1994; FESKE et 61 al. 2003; HOGAN et al. 2003; ARAMBURU et al. 2004). The calcineurin signaling pathway 62 is inhibited by the immunosuppressive and antifungal compounds FK506 and 63 cyclosporin A (CsA), which bind to FK506-binding protein 12 (FKBP12) and cyclophilin A, 64 respectively, forming stable complexes. The FK506-FKBP12 and cyclosporine A- 65 cyclophilin A complexes interact with calcineurin and thereby inhibit the phosphatase 66 activity (O'KEEFE et al. 1992; SCHREIBER AND CRABTREE 1992; SIEKIERKA AND SIGAL 1992; 67 SIGAL AND DUMONT 1992; KISSINGER et al. 1995). 68 While calcineurin is highly conserved in eukaryotes, the functions and biological 69 roles regulated by calcineurin are distinct in mammals and fungi (STEINBACH et al. 70 2007b). In the model yeast Saccharomyces cerevisiae, calcineurin is essential for stress 71 responses, bud emergence, and cell cycle regulation (MIYAKAWA AND MIZUNUMA 2007). In 3 72 yeast, Crz1 (calcineurin responsive zinc finger 1) is a prominent calcineurin substrate 73 that transcriptionally regulates mRNA expression of target genes associated with cell- 74 wall synthesis, ion transport, and vesicle transport (YOSHIMOTO et al. 2002; CYERT 2003). 75 In the major pathogenic fungi, including Candida albicans and Aspergillus fumigatus, 76 the calcineurin signaling pathway plays crucial roles in virulence and stress responses 77 (BADER et al. 2003; BLANKENSHIP et al. 2003; STEINBACH et al. 2006; STEINBACH et al. 78 2007a; STEINBACH et al. 2007b; LEE et al. 2013). Loss of calcineurin causes increased 79 cell sensitivity to stresses including high temperature, salt, cell wall stress, and also 80 results in attenuated or loss of virulence in human pathogenic fungi. Therefore, 81 calcineurin is considered a target for anti-fungal drug discovery and in fact, the 82 immunosuppressants FK506 and cyclosporine A show anti-fungal activity (BRIZUELA et 83 al. 1991; ODOM et al. 1997a). A series of studies also demonstrated that the Crz1 84 orthologs are prominent calcineurin downstream targets in pathogenic fungi (ONYEWU et 85 al. 2004; CRAMER et al. 2008; SCHUMACHER et al. 2008; SORIANI et al. 2008; MIYAZAKI et 86 al. 2010). 87 Cryptococcus neoformans is a ubiquitous fungus that is widespread in the 88 environment including associations with trees, soil, and bird guano (MONARI et al. 1999; 89 IDNURM et al. 2005; CHANG et al. 2014). This fungus is a basidiomycetous fungus and 90 both its spores and desiccated yeast cells serve as infectious propagules (HUNG AND 91 SCHREIBER 1992; KWON-CHUNG et al. 2014). C. neoformans is an opportunistic 92 pathogenic fungus that causes meningoencephalitis in patients who have weakened 93 immune systems, including HIV/AIDS and organ transplant patients, leading to high 94 mortality (KIDD et al. 2004; PARK et al. 2009). In this human pathogenic fungus, 4 95 calcineurin is a key virulence factor that is required for adaptation to stressful host 96 environments including elevated temperature (ODOM et al. 1997b; FOX et al. 2001). In 97 addition, calcineurin is essential for stress adaptation, sexual reproduction, and 98 virulence of C. neoformans (FOX et al. 2001; DANIELSEN et al. 2013). During thermal and 99 other stress conditions, calcineurin co-localizes with components of P-bodies/stress 100 granules (KOZUBOWSKI et al. 2011a; KOZUBOWSKI et al. 2011b) (PBs/SGs) which consist 101 of aggregates of RNA binding proteins, mRNA decay machinery, and translation 102 initiation factors (BUCHAN AND PARKER 2009; MITCHELL et al. 2013; BUCHAN 2014). 103 Recently, our phosphoproteomic analysis identified forty-four putative calcineurin 104 targets in C. neoformans (PARK et al. 2016). We demonstrated that the Crz1 ortholog is 105 a bona fide calcineurin target in C. neoformans. Under thermal stress conditions, 106 calcineurin controls the transcriptional activity and nuclear translocation of Crz1 through 107 dephosphorylation (PARK et al. 2016). In addition, we proposed that several RNA 108 binding proteins including Pbp1 (PAB1-binding protein 1), Puf4 (PUmilio-homology 109 domain Family 4), and Lhp1 are potential calcineurin targets. Pbp1 is involved in fungal 110 virulence and sexual reproduction (PARK et al. 2016). Both Puf4 and Lhp1 are required 111 for heat stress survival (PARK et al. 2016). Employing epistasis analyses, we 112 demonstrated that two downstream branches of the calcineurin pathway govern cell 113 viability at high temperature, sexual reproduction, and fungal virulence (PARK et al. 114 2016). 115 Although we characterized several calcineurin targets, including Crz1 and RNA 116 binding proteins, in our previous study (PARK et al. 2016), many putative targets await 117 characterization. To further characterize the remaining calcineurin targets revealed by 5 118 the above study, we examined stress responses of 13 putative calcineurin-target 119 mutants from a systematic deletion mutant library of C. neoformans (LIU et al. 2008). 120 Among them, the CNAG_01744∆ mutant showed increased sensitivity to cell wall stress 121 in comparison to the WT. Based on BLAST analysis, CNAG_01744 shares considerable 122 homology with the S. cerevisiae Had1 protein. Had1 contains a HAD domain (Haloacid 123 dehalogenase proteins) and is a member of the beta-phosphoglucomutase family of 124 proteins that is highly conserved in most organisms (BURROUGHS et al. 2006; 125 KUZNETSOVA et al. 2015). In yeast, several beta-phosphoglucomutase family proteins, 126 including two 2-deoxyglucose-6-phosphatase (Dog1 and Dog2) and two glycerol-1- 127 phosphate phospohydrolases (Rhr2/Gpp1 and Hor2/Gpp2), are well characterized and 128 are required for cellular responses to environmental stresses such as osmotic and 129 oxidative stresses (RANDEZ-GIL et al. 1995a; RANDEZ-GIL et al. 1995b; NORBECK et al. 130 1996; KUZNETSOVA et al. 2015). Given the relevance of haloacid dehalogenase in stress 131 responses, we were prompted to characterize the role of Had1 in the calcineurin 132 pathway functions in C. neoformans. Our results demonstrate that loss of Had1 causes 133 increased sensitivity to thermal or cell wall stresses and attenuated virulence. To dissect 134 the link between Had1 and Crz1 in calcineurin-related functions, we tested the impact of 135 the had1∆ crz1∆ double mutation. The results show that Crz1 and Had1 play additive 136 roles in thermoresistance and virulence. However, whether Had1 is a direct calcineurin 137 substrate remains to be established. 138 139 MATERIAL AND METHODS 140 Strains, media and culture conditions. Fungal strains used in this study are listed in 6 141 Table 1. Liquid and solid yeast extract-peptone-dextrose (YPD, Difco, Sparks, MD, USA) 142 media were used for general cultures of C. neoformans. To assay thermo-tolerance, 143 fungal cells grown overnight at 30 C were ten-fold diluted, spotted on YPD plates, and 144 then cultured at distinct temperatures (30, 37, 38, and 39C).
Recommended publications
  • Circulating Supar in Two Cohorts of Primary FSGS
    CLINICAL RESEARCH www.jasn.org Circulating suPAR in Two Cohorts of Primary FSGS † ‡ Changli Wei,* Howard Trachtman, Jing Li,* Chuanhui Dong, Aaron L. Friedman,§ | | | Jennifer J. Gassman, June L. McMahan, Milena Radeva, Karsten M. Heil,¶ †† ‡‡ Agnes Trautmann,¶ Ali Anarat,** Sevinc Emre, Gian M. Ghiggeri, Fatih Ozaltin,§§ || ††† Dieter Haffner, Debbie S. Gipson,¶¶ Frederick Kaskel,*** Dagmar-Christiane Fischer, ‡‡‡ Franz Schaefer,¶ and Jochen Reiser, for the PodoNet and FSGS CT Study Consortia Departments of *Medicine and ‡Neurology, University of Miami Miller School of Medicine, Miami, Florida; †Department of Pediatrics, NYU Langone Medical Center, New York, New York; §Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota; |Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio; ¶Center for Pediatric and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany; **Department of Pediatric Nephrology, Cukurova University School of Medicine, Adana, Turkey; ††Department of Pediatrics, Istanbul Medical Faculty, University of Istanbul, Istanbul, Turkey; ‡‡Division of Nephrology, Dialysis, and Transplantation, Laboratory on Pathophysiology of Uremia, G. Gaslini Children’s Hospital, Genoa, Italy; §§Pediatric Nephrology Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey; ||Department of Pediatric Kidney, Liver, and Metabolic Diseases, Hannover Medical School, Hannover, Germany; ¶¶Department of Pediatrics, University of Michigan, Ann Arbor, Michigan; ***Children’s Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York; †††Department of Pediatrics, Rostock University Hospital, Rostock, Germany; and ‡‡‡Department of Medicine, Rush University Medical Center, Chicago, Illinois ABSTRACT Overexpression of soluble urokinase receptor (suPAR) causes pathology in animal models similar to pri- mary FSGS, and one recent study demonstrated elevated levels of serum suPAR in patients with the disease.
    [Show full text]
  • Regulation of Calmodulin-Stimulated Cyclic Nucleotide Phosphodiesterase (PDE1): Review
    95-105 5/6/06 13:44 Page 95 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 18: 95-105, 2006 95 Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): Review RAJENDRA K. SHARMA, SHANKAR B. DAS, ASHAKUMARY LAKSHMIKUTTYAMMA, PONNIAH SELVAKUMAR and ANURAAG SHRIVASTAV Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Cancer Research Division, Saskatchewan Cancer Agency, 20 Campus Drive, Saskatoon SK S7N 4H4, Canada Received January 16, 2006; Accepted March 13, 2006 Abstract. The response of living cells to change in cell 6. Differential inhibition of PDE1 isozymes and its environment depends on the action of second messenger therapeutic applications molecules. The two second messenger molecules cAMP and 7. Role of proteolysis in regulating PDE1A2 Ca2+ regulate a large number of eukaryotic cellular events. 8. Role of PDE1A1 in ischemic-reperfused heart Calmodulin-stimulated cyclic nucleotide phosphodiesterase 9. Conclusion (PDE1) is one of the key enzymes involved in the complex interaction between cAMP and Ca2+ second messenger systems. Some PDE1 isozymes have similar kinetic and 1. Introduction immunological properties but are differentially regulated by Ca2+ and calmodulin. Accumulating evidence suggests that the A variety of cellular activities are regulated through mech- activity of PDE1 is selectively regulated by cross-talk between anisms controlling the level of cyclic nucleotides. These Ca2+ and cAMP signalling pathways. These isozymes are mechanisms include synthesis, degradation, efflux and seque- also further distinguished by various pharmacological agents. stration of cyclic adenosine 3':5'-monophosphate (cAMP) and We have demonstrated a potentially novel regulation of PDE1 cyclic guanosine 3':5'- monophosphate (cGMP) within the by calpain.
    [Show full text]
  • The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease Jonathan Z
    REVIEW pubs.acs.org/CR The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease Jonathan Z. Long* and Benjamin F. Cravatt* The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States CONTENTS 2.4. Other Phospholipases 6034 1. Introduction 6023 2.4.1. LIPG (Endothelial Lipase) 6034 2. Small-Molecule Hydrolases 6023 2.4.2. PLA1A (Phosphatidylserine-Specific 2.1. Intracellular Neutral Lipases 6023 PLA1) 6035 2.1.1. LIPE (Hormone-Sensitive Lipase) 6024 2.4.3. LIPH and LIPI (Phosphatidic Acid-Specific 2.1.2. PNPLA2 (Adipose Triglyceride Lipase) 6024 PLA1R and β) 6035 2.1.3. MGLL (Monoacylglycerol Lipase) 6025 2.4.4. PLB1 (Phospholipase B) 6035 2.1.4. DAGLA and DAGLB (Diacylglycerol Lipase 2.4.5. DDHD1 and DDHD2 (DDHD Domain R and β) 6026 Containing 1 and 2) 6035 2.1.5. CES3 (Carboxylesterase 3) 6026 2.4.6. ABHD4 (Alpha/Beta Hydrolase Domain 2.1.6. AADACL1 (Arylacetamide Deacetylase-like 1) 6026 Containing 4) 6036 2.1.7. ABHD6 (Alpha/Beta Hydrolase Domain 2.5. Small-Molecule Amidases 6036 Containing 6) 6027 2.5.1. FAAH and FAAH2 (Fatty Acid Amide 2.1.8. ABHD12 (Alpha/Beta Hydrolase Domain Hydrolase and FAAH2) 6036 Containing 12) 6027 2.5.2. AFMID (Arylformamidase) 6037 2.2. Extracellular Neutral Lipases 6027 2.6. Acyl-CoA Hydrolases 6037 2.2.1. PNLIP (Pancreatic Lipase) 6028 2.6.1. FASN (Fatty Acid Synthase) 6037 2.2.2. PNLIPRP1 and PNLIPR2 (Pancreatic 2.6.2.
    [Show full text]
  • PDE6) by the Glutamic Acid- Rich Protein-2 (GARP2)
    University of New Hampshire University of New Hampshire Scholars' Repository Doctoral Dissertations Student Scholarship Fall 2013 Regulation of the catalytic and allosteric properties of photoreceptor phosphodiesterase (PDE6) by the glutamic acid- rich protein-2 (GARP2) Wei Yao Follow this and additional works at: https://scholars.unh.edu/dissertation Recommended Citation Yao, Wei, "Regulation of the catalytic and allosteric properties of photoreceptor phosphodiesterase (PDE6) by the glutamic acid-rich protein-2 (GARP2)" (2013). Doctoral Dissertations. 747. https://scholars.unh.edu/dissertation/747 This Dissertation is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of University of New Hampshire Scholars' Repository. For more information, please contact [email protected]. REGULATION OF THE CATALYTIC AND ALLOSTERIC PROPERTIES OF PHOTORECEPTOR PHOSPHODIESTERASE (PDE6) BY THE GLUTAMIC ACID-RICH PROTEIN-2 (GARP2) BY WEI YAO B.S., Jinan University, 2007 DISSERTATION Submitted to the University of New Hampshire in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Biochemistry September, 2013 UMI Number: 3575987 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. Di!ss0?t&iori Piiblist’Mlg UMI 3575987 Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
    [Show full text]
  • Supplementary Table 3: Calcineurin- and Aging-Sensitive Genes
    Supplementary Table 3: Calcineurin- and Aging-Sensitive Genes Supplementary Table 3: Calcineurin up/ Aging up (pages 1 -2)- genes classified as Ad-aCaN up in the present study (see Supplementary Table 1), as well as reported as significantly increased in our prior aging study (Blalock et al., 2003, see supplementary tables 3, 4 and 5). Calcineurin Down/ Aging Down (page 2), Calcineurin Up/ Aging Down (pages 2-3),and Calcineurin Down/Aging Up (page 3)as above except for direction of change. - Columns: Probe Set- Affymetrix probe set identifier for RG-U34A microarray, Symbol and Title- annotated information for above probe set (annotation downloaded June, 2004), Calcineurin ANOVA- p-value for 1-way Analysis of Variance. Calcineurin Up/Aging Up Probe set Symbol Title CaN ANOVA rc_AI170268_at B2m beta-2 microglobulin 0.00000 rc_AI102299_s_at Bid3 BH3 interacting domain 3 0.00721 X52477_at C3 complement component 3 0.00000 X58294_at Ca2 carbonic anhydrase 2 0.00004 X76489cds_g_at Cd9 CD9 antigen 0.00000 L07736_at Cpt1a carnitine palmitoyltransferase 1, liver 0.00001 M55534mRNA_s_at Cryab crystallin, alpha B 0.00000 X60351cds_s_at Cryab crystallin, alpha B 0.00000 rc_AI234146_at Csrp1 cysteine and glycine-rich protein 1 0.00000 rc_AI176595_s_at Ctsl cathepsin L 0.00001 D00569_at Decr1 2,4-dienoyl CoA reductase 1, mitochondrial 0.00000 rc_AA924925_at Dri42 ER transmembrane protein Dri 42 0.00000 rc_AA848831_at Edg2 endothelial differentiation, lysophosphatidic acid GPCR, 2 0.00000 X14323cds_g_at Fcgrt Fc receptor, IgG, alpha chain transporter
    [Show full text]
  • Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights Since 2016
    International Journal of Molecular Sciences Review Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016 Susann Schröder 1,2,* , Matthias Scheunemann 2, Barbara Wenzel 2 and Peter Brust 2 1 Department of Research and Development, ROTOP Pharmaka Ltd., 01328 Dresden, Germany 2 Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 04318 Leipzig, Germany; [email protected] (M.S.); [email protected] (B.W.); [email protected] (P.B.) * Correspondence: [email protected]; Tel.: +49-341-234-179-4631 Abstract: Cyclic nucleotide phosphodiesterases (PDEs) represent one of the key targets in the research field of intracellular signaling related to the second messenger molecules cyclic adenosine monophosphate (cAMP) and/or cyclic guanosine monophosphate (cGMP). Hence, non-invasive imaging of this enzyme class by positron emission tomography (PET) using appropriate isoform- selective PDE radioligands is gaining importance. This methodology enables the in vivo diagnosis and staging of numerous diseases associated with altered PDE density or activity in the periphery and the central nervous system as well as the translational evaluation of novel PDE inhibitors as therapeutics. In this follow-up review, we summarize the efforts in the development of novel PDE radioligands and highlight (pre-)clinical insights from PET studies using already known PDE Citation: Schröder, S.; Scheunemann, radioligands since 2016. M.; Wenzel, B.; Brust, P. Challenges on Cyclic Nucleotide Keywords: positron emission tomography; cyclic nucleotide phosphodiesterases; PDE inhibitors; Phosphodiesterases Imaging with PDE radioligands; radiochemistry; imaging; recent (pre-)clinical insights Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016.
    [Show full text]
  • Modulation of the Camp Levels with a Conserved Actinobacteria Phosphodiesterase 2 Enzyme Reduces Antimicrobial Tolerance in Mycobacteria
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.26.267864; this version posted August 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Modulation of the cAMP levels with a conserved actinobacteria phosphodiesterase 2 enzyme reduces antimicrobial tolerance in mycobacteria 3 4 Michael Thomson1, Kanokkan Nunta1, Ashleigh Cheyne1, Yi liu1, Acely Garza-Garcia2 and 5 Gerald Larrouy-Maumus1† 6 7 1MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, 8 Faculty of Natural Sciences, Imperial College London, London, SW7 2AZ, UK 9 2The Francis Crick Institute, London NW1 1AT, United Kingdom. 10 11 †Corresponding author: 12 13 Dr Gerald Larrouy-Maumus 14 MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Faculty 15 of Natural Sciences, Imperial College London, London, SW7 2AZ, UK 16 Telephone: +44 (0) 2075 947463 17 E-mail: [email protected] 18 19 20 1 e ag P 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.26.267864; this version posted August 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 21 Abstract 22 Antimicrobial tolerance (AMT) is the gateway to the development of antimicrobial resistance 23 (AMR) and is therefore a major issue that needs to be addressed. 24 The second messenger cyclic-AMP (cAMP), which is conserved across all taxa, is involved 25 in propagating signals from environmental stimuli and converting these into a response.
    [Show full text]
  • Kinase-Inactive ZAP-70 Thymocyte Development By
    An Improved Retroviral Gene Transfer Technique Demonstrates Inhibition of CD4− CD8− Thymocyte Development by Kinase-Inactive ZAP-70 This information is current as of September 23, 2021. Takehiko Sugawara, Vincenzo Di Bartolo, Tadaaki Miyazaki, Hiromitsu Nakauchi, Oreste Acuto and Yousuke Takahama J Immunol 1998; 161:2888-2894; ; http://www.jimmunol.org/content/161/6/2888 Downloaded from References This article cites 49 articles, 28 of which you can access for free at: http://www.jimmunol.org/content/161/6/2888.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 23, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. An Improved Retroviral Gene Transfer Technique Demonstrates Inhibition of CD42CD82 Thymocyte Development by Kinase-Inactive ZAP-701 Takehiko Sugawara,* Vincenzo Di Bartolo,§ Tadaaki Miyazaki,‡ Hiromitsu Nakauchi,* Oreste Acuto,§ and Yousuke Takahama2*† ZAP-70 is a Syk family tyrosine kinase that plays an essential role in initiating TCR signals.
    [Show full text]
  • Development of Phosphodiesterase-Protein Kinase Complexes As Novel Targets for Discovery of Inhibitors with Enhanced Spec- Ificity
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 6 April 2021 doi:10.20944/preprints202104.0174.v1 Article Development of Phosphodiesterase-Protein Kinase complexes as novel targets for discovery of inhibitors with enhanced spec- ificity Nikhil K. Tulsian 1,2, Valerie Jia-En Sin 3, Hwee-Ling Koh 3,*, Ganesh S. Anand 1,4,* 1 Department of Biological Sciences, 14 Science Drive 4, National University of Singapore, Singapore – 117543 2 Department of Biochemistry, 28 Medical Drive, National University of Singapore, Singapore – 117546 3 Department of Pharmacy, 18 Science Drive 4, National University of Singapore, Singapore – 117543 4 Department of Chemistry, The Pennsylvania State University, Philadelphia, United States of America - 16801 * Correspondence: KHL: [email protected]; Tel.: +6565167962; GSA: [email protected]; Tel.: 814-867-1944 Abstract: Phosphodiesterases (PDEs) hydrolyze cyclic nucleotides to modulate multiple signaling events in cells. PDEs are recognized to actively associate with cyclic nucleotide receptors (Protein Kinases, PK) in larger macromolecular assemblies referred to as signalosomes. Complexation of PDEs with PK generates an expanded active site which enhances PDE activity. This facilitates signal- osome-associated PDEs to preferentially catalyze active hydrolysis of cyclic nucleotides bound to PK, and aid in signal termination. PDEs are important drug targets and current strategies for inhib- itor discovery are based entirely on targeting conserved PDE catalytic domains. This often results in inhibitors with cross-reactivity amongst closely related PDEs and attendant unwanted side ef- fects. Here, our approach targets PDE-PK complexes as they would occur in signalosomes, thereby offering greater specificity. Our developed fluorescence polarization assay has been adapted to identify inhibitors that block cyclic nucleotide pockets in PDE-PK complexes in one mode, and dis- rupt protein-protein interactions between PDEs and cyclic nucleotide activating protein kinases in a second mode.
    [Show full text]
  • A-Kinase Anchoring Protein–Calcineurin Signaling in Long-Term Depression of Gabaergic Synapses
    2650 • The Journal of Neuroscience, February 6, 2013 • 33(6):2650–2660 Cellular/Molecular A-Kinase Anchoring Protein–Calcineurin Signaling in Long-Term Depression of GABAergic Synapses Matthieu Dacher, Shawn Gouty, Steven Dash, Brian M. Cox, and Fereshteh S. Nugent Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 The postsynaptic scaffolding A-kinase anchoring protein 79/150 (AKAP79/150) signaling complex regulates excitatory synaptic trans- mission and strength through tethering protein kinase A (PKA), PKC, and calcineurin (CaN) to the postsynaptic densities of neurons (Sanderson and Dell’Acqua, 2011), but its role in inhibitory synaptic transmission and plasticity is unknown. Using immunofluorescence and whole-cell patch-clamp recording in rat midbrain slices, we show that activation of postsynaptic D2-like family of dopamine (DA) receptor in the ventral tegmental area (VTA) induces long-term depression (LTD) of GABAergic synapses on DA neurons through an inositol triphosphate receptor-mediated local rise in postsynaptic Ca 2ϩ and CaN activation accompanied by PKA inhibition, which requires AKAP150 as a bridging signaling molecule. Our data also illuminate a requirement for a clathrin-mediated internalization of GABAA receptors in expression of LTDGABA. Moreover, disruption of AKAP–PKA anchoring does not affect glutamatergic synapses onto DA neurons, suggesting that the PKA–AKAP–CaN complex is uniquely situated at GABAA receptor synapses in VTA DA neurons to regulate plasticity associated with GABAA receptors. Drug-induced modulation of GABAergic plasticity in the VTA through such novel signaling mechanisms has the potential to persistently alter the output of individual DA neurons and of the VTA, which may contribute to the reinforcing or addictive properties of drugs of abuse.
    [Show full text]
  • Soluble Epoxide Hydrolase Inhibition Protected Against Angiotensin II
    www.nature.com/scientificreports OPEN Soluble Epoxide Hydrolase Inhibition Protected against Angiotensin II-induced Adventitial Received: 6 April 2017 Accepted: 29 June 2017 Remodeling Published online: 31 July 2017 Chi Zhou, Jin Huang, Qing Li, Jiali Nie, Xizhen Xu & Dao Wen Wang Epoxyeicosatrienoic acids (EETs), the metabolites of cytochrome P450 epoxygenases derived from arachidonic acid, exert important biological activities in maintaining cardiovascular homeostasis. Soluble epoxide hydrolase (sEH) hydrolyzes EETs to less biologically active dihydroxyeicosatrienoic acids. However, the efects of sEH inhibition on adventitial remodeling remain inconclusive. In this study, the adventitial remodeling model was established by continuous Ang II infusion for 2 weeks in C57BL/6 J mice, before which sEH inhibitor 1-trifuoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) was administered by gavage. Adventitial remodeling was evaluated by histological analysis, western blot, immunofuorescent staining, calcium imaging, CCK-8 and transwell assay. Results showed that Ang II infusion signifcantly induced vessel wall thickening, collagen deposition, and overexpression of α-SMA and PCNA in aortic adventitia, respectively. Interestingly, these injuries were attenuated by TPPU administration. Additionally, TPPU pretreatment overtly prevented Ang II-induced primary adventitial fbroblasts activation, characterized by diferentiation, proliferation, migration, and collagen synthesis via Ca2+-calcineurin/NFATc3 signaling pathway in vitro. In summary, our results suggest that inhibition of sEH could be considered as a novel therapeutic strategy to treat adventitial remodeling related disorders. Aorta is composed of three tunicae: intima, media and adventitia. Te roles of intima and media on vascular functions have been extensively studied, while the contribution of adventitia to vascular functions was recently recognized.
    [Show full text]
  • Management of Steroid-Resistant Nephrotic Syndrome in Children and Adolescents
    Review Management of steroid-resistant nephrotic syndrome in children and adolescents Kjell Tullus, Hazel Webb, Arvind Bagga More than 85% of children and adolescents (majority between 1–12 years old) with idiopathic nephrotic syndrome Lancet Child Adolesc Health 2018 show complete remission of proteinuria following daily treatment with corticosteroids. Patients who do not show Published Online remission after 4 weeks’ treatment with daily prednisolone are considered to have steroid-resistant nephrotic October 17, 2018 syndrome (SRNS). Renal histology in most patients shows presence of focal segmental glomerulosclerosis, minimal http://dx.doi.org/10.1016/ S2352-4642(18)30283-9 change disease, and (rarely) mesangioproliferative glomerulonephritis. A third of patients with SRNS show mutations Nephrology Unit, Great in one of the key podocyte genes. The remaining cases of SRNS are probably caused by an undefined circulating Ormond Street Hospital for factor. Treatment with calcineurin inhibitors (ciclosporin and tacrolimus) is the standard of care for patients with Children, Great Ormond Street, non-genetic SRNS, and approximately 70% of patients achieve a complete or partial remission and show satisfactory London, UK (K Tullus MD, long-term outcome. Additional treatment with drugs that inhibit the renin–angiotensin axis is recommended for H Webb BSc) andDivision of Nephrology, Indian Council of hypertension and for reducing remaining proteinuria. Patients with SRNS who do not respond to treatment with Medical Research Advanced calcineurin inhibitors or other immunosuppressive drugs can show declining kidney function and are at risk for end- Center for Research in stage renal failure. Approximately a third of those who undergo renal transplantation show recurrent focal segmental Nephrology, All India Institute glomerulosclerosis in the allograft and often respond to combined treatment with plasma exchange, rituximab, and of Medical Sciences, New Delhi, India (Prof A Bagga MD) intensified immunosuppression.
    [Show full text]